Are calcium antagonists the best option in elderly hypertensives?

F Forette1, P Bert, A S Rigaud

  • 1Broca Hospital, Paris, France.

Insights

Calcium antagonists are safe and effective for elderly patients with hypertension. This study found no adverse effects in elderly individuals treated with nicardipine, supporting their use in this population.

Area of Science:

  • Cardiology
  • Geriatrics
  • Pharmacology

Background:

  • Elderly hypertension often involves increased peripheral resistance and decreased arterial compliance.
  • Calcium antagonists target intracellular calcium concentration in smooth muscles, inhibiting calcium influx and promoting vasodilation.
  • The mechanism of calcium antagonists is particularly suited for treating hypertension in older adults.

Purpose of the Study:

  • To evaluate the efficacy and safety of calcium antagonists in elderly hypertensive patients.
  • To investigate the effects of nicardipine on electrocardiogram, vital signs, and laboratory parameters in the elderly.
  • To explore potential protective effects against atherosclerosis and cerebral ischemia.

Main Methods:

  • A double-blind, placebo-controlled study involving 31 elderly hypertensive patients.
  • Treatment with nicardipine was administered and monitored for specific physiological and biochemical changes.
  • Review of experimental evidence regarding atherosclerotic protection and cerebral effects.

Main Results:

  • No consistent electrocardiogram changes were observed with nicardipine treatment.
  • No significant alterations in heart rate, plasma electrolytes, creatinine, uric acid, or postural hypotension were detected.
  • Experimental data suggests potential protective effects against atherosclerosis and cerebral ischemia, though human extrapolation is debated.

Conclusions:

  • Calcium antagonists, exemplified by nicardipine, are safe and effective for treating hypertension in the elderly.
  • Their vasodilatory mechanism aligns well with the pathophysiology of hypertension in this demographic.
  • Further research may elucidate beneficial cerebral effects and cardioprotective roles in elderly populations.

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...